Searched for
GENERIC EPILEPSY MEDICINE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
- Possibility and probability favour them in war and peace: 10 large-cap stocks from 2 sectors with upside potential of up to 28%Probability theory is important in the stock market. Reason: Stock prices are a function of many factors and the underlying operating matri...
- Indoco Remedies gets USFDA nod to sell generic epilepsy medicineIndoco Remedies has secured approval from the US health regulator for its generic Lacosamide oral solution. This medication is used to trea...
- Indian drugmaker Zee Laboratories promises cheap alternatives - but there's a catchZee Laboratories' drugs face persistent quality issues, with over 86 failed regulatory tests in India and abroad. Despite multiple prosecut...
- Keys to wealth creation: Strong balance sheet & patience. 5 large-cap stocks from different sectors with upside potential of up to 38%Events come and go, but investing principles are constant. So, in times like these, it’s best to ignore the noise and the narrative that co...
- Pharma shares slip up to 3% as Trump order to boost U.S. drug manufacturing rattles Indian exportersIndian pharmaceutical stocks experienced a significant decline. This followed US President Donald Trump's executive order. The order aims t...
- In volatile times, defensive stocks or defensive businesses? The two are different. 7 stocks from second category with an upside potential of up to 32%Last Friday was probably the sixth time in 2024 that practically all sectoral indices were in the red. Needless to say, the market breadth ...
- Indian pharma companies faked generic viagra data to gain approval, finds US FDAFDA's June 18 alert revealed falsified data by Synapse Labs affecting generics like Umedica's Viagra. Europe had earlier warned. Insurers m...
- Manufacturing issues led drug makers Glenmark, Sun Pharma, Dr Reddy's to recall products in USAs per the US health regulator, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may caus...
- New policy likely to resolve drug name anomalyThe government has geared up to resolve the confusion, restricting companies from using same brand names for different drugs. The health mi...
- Retail margin on generic drugs may be as high as 1,000%, claims studyPM Narendra Modi had on Monday said that government is contemplating a legislation that will make it mandatory for the doctors to prescribe...
- Germany bans 80 generic drugs for insufficient trials by GVKThe regulator said it had informed the drugs manufacturers about its decision on Monday and the ban on the sales of medicines came into eff...
- Take steps to stop use of adulterated drugs in India: Rajinder SacharFormer chief justice of Delhi High Court Rajinder Sachar has demanded that Indian authorities take steps to stop their use in the country.
- Pfizer profit dips 2 percent, sales fall much morePfizer Inc posted a 2 percent drop in first-quarter profit Tuesday, as cost-cutting by the world's largest drugmaker couldn't offset big dr...
- Pharma action hots up: UCB acquires Schwarz for $5.6bnUCB, the Belgian maker of the allergy drug Zyrtec, agreed to buy Schwarz Pharma for E4.4bn ($5.6bn) in cash and stock to gain new medicines...
Load More
